User profiles for Elie Gertner

Elie Gertner

University of Minnesota Medical School
Verified email at umn.edu
Cited by 2211

[PDF][PDF] Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome

…, A Boothby, E Gertner - ACR open rheumatology, 2020 - Wiley Online Library
Objective The objective of this study was to report the benefit of a therapeutic approach
consisting of intravenous ( IV ) continuous anakinra (recombinant human interleukin‐1 receptor …

Guidelines for treatment of Susac syndrome–An update

…, N Asdaghi, S Srivastava, E Gertner - … journal of stroke, 2020 - journals.sagepub.com
Susac syndrome is an immune-mediated, pauci-inflammatory, ischemia-producing, occlusive
microvascular endotheliopathy/basement membranopathy that affects the brain, retina, …

Working memory capacity is decreased in sleep-deprived internal medicine residents

A Gohar, A Adams, E Gertner… - Journal of Clinical …, 2009 - jcsm.aasm.org
Background: Concerns about medical errors due to sleep deprivation during residency training
led the Accreditation Council for Graduate Medical Education to mandate reductions in …

Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels

I Ahmed, E Gertner - The American journal of medicine, 2012 - Elsevier
BACKGROUND: Arthrocentesis and joint injections are commonly performed for both
diagnostic and therapeutic indications. Because of safety concerns, there is often reluctance to …

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator …

I Ahmed, E Gertner, WB Nelson, CM House, R Dahiya… - Heart Rhythm, 2010 - Elsevier
BACKGROUND: Current guidelines recommend stopping oral anticoagulation and starting
bridging anticoagulation with intravenous heparin or subcutaneous enoxaparin when …

Complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs

E Gertner, PS Marshall, D Filandrinos… - … : Official Journal of …, 1995 - Wiley Online Library
Objective. Many patients with chronic disease use alternative therapies. Our objective was
to investigate complications resulting from the use of Chinese herbal medications containing …

[HTML][HTML] Off‐label therapies for COVID‐19—Are we all in this together?

JD Alpern, E Gertner - Clinical pharmacology and therapeutics, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) continues to spread rapidly
outside of mainland China. As of April 6, 2020, there are over 300,000 cases and 10,000 …

Anakinra for the treatment of acute severe gout in critically ill patients

JT Thueringer, NK Doll, E Gertner - Seminars in Arthritis and Rheumatism, 2015 - Elsevier
Objectives To report on the efficacy and safety of anakinra for treatment of acute gouty
arthritis in medically complex, critically ill patients. Methods Retrospective chart review of 13 …

[HTML][HTML] Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report

L Ngo, E Miller, P Valen, E Gertner - Journal of medical case reports, 2018 - Springer
Background Novel immune checkpoint inhibitors have been often utilized for different types
of malignancies as salvage therapy with varying success. One obstacle to immune …

Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment.

E Gertner - The Journal of Rheumatology, 1999 - europepmc.org
Objective To describe clinical manifestations, laboratory findings, and treatment of patients
with the antiphospholipid syndrome (APS) who develop diffuse alveolar hemorrhage. …